MMEDV — Minimed Cashflow Statement
0.000.00%
Last trade - 00:00- $5.06bn
- $4.86bn
- $3.10bn
Annual cashflow statement for Minimed, fiscal year end - April 24th, USD millions except per share, conversion factor applied.
2023 April 28th | 2024 April 26th | 2025 April 25th | 2026 April 24th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -92 | -107 | -198 | -317 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 74 | 89 | 75 | 184 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -92 | -73 | 122 | -166 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Accounts Payable | ||||
| Change in Payable / Accrued Expenses | ||||
| Net Change in Other Assets & Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -6 | 41 | 140 | -197 |
| Capital Expenditures | -167 | -148 | -193 | -223 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -13 | -9 | — | -10 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -180 | -157 | -193 | -233 |
| Financing Cash Flow Items | 185 | 112 | 10 | 178 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 185 | 112 | 10 | 716 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -1 | -4 | 0 | 287 |